A pharmacophore for human pregnane X receptor ligands

被引:140
作者
Ekins, S [1 ]
Erickson, JA [1 ]
机构
[1] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA
关键词
D O I
10.1124/dmd.30.1.96
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The pregnane X receptor (PXR) is involved in transcriptional regulation of multiple cytochromes P450 and multidrug resistance-associated protein (MDR1), which encodes for the drug transporter P-glycoprotein. Crystal structure analyses suggest that the ligand binding domain is highly hydrophobic and flexible, allowing molecules of differing sizes to bind in multiple orientations. Using literature data for EC50 (half-maximal inhibitory concentration) values for PXR activation derived for 12 human PXR ligands, a pharmacophore was developed. This pharmacophore supports the hydrophobic nature of the ligand binding domain recently deduced from the X-ray crystal structure because it contains four hydrophobic regions and one hydrogen bond acceptor. These features are consistent with at least one of the three experimentally determined orientations in which SR12813 binds to PXR, as determined by overlay studies. SR12813 fulfills all of the five pharmacophore features, as does the potent ligand hyperforin. The pharmacophore was also used to predict the binding affinity for 28 molecules not In the model but known to be PXR ligands of differing potencies. The pharmacophore distinguished the most potent activators of PXR (that display >5-fold activation/deactivation), like ecteinascidin, troglitazone, nifedipine, and dexamethasone-t-butylacetate, from poor activators, such as scopoletin and kaempferol. The model could be useful in drug development, potentially acting as a high-throughput filter for identifying compounds that may bind to PXR before in vitro determination. Ultimately, this will aid in the selection of molecules with a lesser capacity to be patent PXR ligands and thus avoid induction of numerous drug-metabolizing enzymes and MDR1.
引用
收藏
页码:96 / 99
页数:4
相关论文
共 17 条
  • [11] St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor
    Moore, LB
    Goodwin, B
    Jones, SA
    Wisely, GB
    Serabjit-Singh, CJ
    Willson, TM
    Collins, JL
    Kliewer, SA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (13) : 7500 - 7502
  • [12] Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands
    Moore, LB
    Parks, DJ
    Jones, SA
    Bledsoe, RK
    Consler, TG
    Stimmel, JB
    Goodwin, B
    Liddle, C
    Blanchard, SG
    Willson, TM
    Collins, JL
    Kliewer, SA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (20) : 15122 - 15127
  • [13] Promiscuous regulator of xenobiotic removal
    Schuetz, E
    Strom, S
    [J]. NATURE MEDICINE, 2001, 7 (05) : 536 - 537
  • [14] The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity
    Staudinger, JL
    Goodwin, B
    Jones, SA
    Hawkins-Brown, D
    MacKenzie, KI
    Latour, A
    Liu, YP
    Klaassen, CD
    Brown, KK
    Reinhard, J
    Willson, TN
    Koller, BH
    Kliewer, SA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (06) : 3369 - 3374
  • [15] The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux
    Synold, TW
    Dussault, I
    Forman, BM
    [J]. NATURE MEDICINE, 2001, 7 (05) : 584 - 590
  • [16] The human nuclear xenobiotic receptor PXR: Structural determinants of directed promiscuity
    Watkins, RE
    Wisely, GB
    Moore, LB
    Collins, JL
    Lambert, MH
    Williams, SP
    Willson, TM
    Kliewer, SA
    Redinbo, MR
    [J]. SCIENCE, 2001, 292 (5525) : 2329 - 2333
  • [17] The cytochrome P450 3A4 inducer metyrapone is an activator of the human pregnane X receptor
    Wright, MC
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 1999, 27 (04) : 387 - 391